Decision: UK Anti-Doping v Harry Reardon

Decision: UK Anti-Doping v Harry Reardon

A Decision in the case of UK Anti-Doping v Harry Reardon (RFL) has been published by the National Anti-Doping Panel (NADP).

On 15 July 2017, Mr Reardon was subject to an Out-of-Competition test at a training session for Rochdale Hornets RLFC at Warrington Wolves Training Facility.

Analysis of Mr Reardon’s urine sample returned an Adverse Analytical Finding (“AAF”) for two prohibited substances, 2α-methyl-5α-androstan-3α-οl-17-one (a metabolite of drostanolone) and 19-norandrosterone.

Mr Reardon was subsequently charged with committing an Anti-Doping Rule Violation (ADRV) for the Presence of a Prohibited Substance under UK Anti-Doping Rule (ADR) Article 2.1 and the matter referred to the NADP for determination at Mr Reardon’s request.

The NADP Tribunal consisting of Mr David Casement QC (Chairman), Dr Kitrina Douglas and Prof. Dorian Haskard determined that, as Mr Reardon did not take up the opportunity to place evidence before the Tribunal so as to reduce the applicable sanction, he could not discharge the burden placed upon him under Anti-Doping Rule (ADR) Article 10.2.3. The applicable sanction imposed by the Tribunal was therefore four years, commencing on 30 November 2017.

The full NADP Decision can be accessed via the related links tab on the right-hand side.

The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping, who are responsible for investigating, charging and prosecuting cases before the NADP.